Reduced-dose combination chemotherapy (S-1 plus oxaliplatin) versus full-dose monotherapy (S-1) in older vulnerable patients with metastatic colorectal cancer (NORDIC9): a randomised, open-label phase 2 trial-Reference-Cited by-同舟云学术

Reduced-dose combination chemotherapy (S-1 plus oxaliplatin) versus full-dose monotherapy (S-1) in older vulnerable patients with metastatic colorectal cancer (NORDIC9): a randomised, open-label phase 2 trial

Published:2019-05 Issue:5 Volume:4 Page:376-388
ISSN:2468-1253
Container-title:The Lancet Gastroenterology & Hepatology
language:en
Short-container-title:The Lancet Gastroenterology & Hepatology

Author:

Winther Stine Braendegaard,Liposits Gabor,Skuladottir Halla,Hofsli Eva,Shah Carl-Henrik,Poulsen Laurids Østergaard,Ryg Jesper,Osterlund Pia,Berglund Åke,Qvortrup Camilla,Glimelius Bengt,Sorbye Halfdan,Pfeiffer Per

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference31 articles.

1. Under-representation of older adults in cancer registration trials: known problem, little progress;Scher;J Clin Oncol,2012

2. Patient characteristics and stratification in medical treatment studies for metastatic colorectal cancer: a proposal for standardization of patient characteristic reporting and stratification;Sorbye;Ann Oncol,2007

3. Trends in colorectal cancer in the elderly in Denmark, 1980–2012;Braendegaard Winther;Acta Oncol,2016

4. Treatment of colorectal cancer in older patients: International Society of Geriatric Oncology (SIOG) consensus recommendations 2013;Papamichael;Ann Oncol,2015

5. ESMO consensus guidelines for the management of patients with metastatic colorectal cancer;Van Cutsem;Ann Oncol,2016

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of comprehensive geriatric assessment on hospitalizations in older adults with frailty initiating curatively intended oncologic treatment: The PROGNOSIS-RCT study;Journal of Geriatric Oncology;2024-09

2. Physical decline, falls, and hospitalization among vulnerable older patients in the trajectory of colorectal cancer treatment;Journal of Geriatric Oncology;2024-09

3. Time toxicity among older patients with cancer treated with palliative systemic therapy;Supportive Care in Cancer;2024-08-30

4. DOSAGE study: protocol for a phase III non-inferiority randomised trial investigating dose-reduced chemotherapy for advanced colorectal cancer in older patients;BMJ Open;2024-08

5. How to Balance Prognostic Factors in Controlled Phase II Trials: Stratified Permuted Block Randomization or Minimization? An Analysis of Clinical Trials in Digestive Oncology;Current Oncology;2024-06-17